Activated Mast Cells in Proximity to Colonic Nerves Correlate with Abdominal Pain in Irritable Bowel Syndrome

Gastroenterology

Volumn 126, Issue 3, 2004, Pages 693-702

  Barbara, Giovanni ^a,d   Stanghellini, Vincenzo ^a   De Giorgio, Roberto ^a   Cremon, Cesare ^a   Cottrell, Graeme S ^b   Santini, Donatella ^a   Pasquinelli, Gianandrea ^a   Morselli Labate, Antonio M ^a   Grady, Eileen F ^b   Bunnett, Nigel W ^b   Collins, Stephen M ^c   Corinaldesi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; TRYPTASE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; COMPUTER ANALYSIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HISTAMINE RELEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; INTESTINE MUCOSA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NERVE FIBER; NOCICEPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 10744225624     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.11.055     Document Type: Article

References (54)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):S43-S47.
2. Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314-318.
3. Stanghellini V, Cogliandro R, Barbara G, De Giorgio R, Cogliandro L, Corinaldesi R. Motor function and dysfunction in functional dyspepsia and irritable bowel syndrome. In: Holtmann G, Talley NJ, eds. Gastrointestinal inflammation and disturbed gut function: the challenge of new concepts. Dordrecht: Kluwer Academic Publishers, 2003:176-186.
4. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-668.
5. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002;51(suppl 1):i41-i44.
6. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-1671.
7. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783.
8. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993;38:1590-1595.
9. Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-1979.
10. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, Read NW. Psychometric scores and persistence of irritable bowel after infectious diarrhea. Lancet 1996;347:150-153.
11. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997;314:779-782.
12. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-192.
13. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-457.
14. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-585.
15. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci U S A 1987;84:2975-2979.
16. Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW, Vanner SJ. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 2003;547:531-542.
17. Gao C, Liu S, Hu HZ, Gao N, Kim G, Xia Y, Wood JD. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 2002;123:1554-1564.
18. Nozdrachev AD, Akoev GN, Filippova LV, Sherman NO, Lioudyno MI, Makarov FN. Changes in afferent impulse activity of small intestine mesenteric nerves in response to antigen challenge. Neuroscience 1999;94:1339-1342.
19. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997;112:1714-1743.
20. Castex N, Fioramonti J, Fargeas MJ, More J, Bueno L. Role of 5-HT3 receptors and afferent fibers in the effects of mast cell degranulation on colonic motility in rats. Gastroenterology 1994;107:976-984.
21. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079.
22. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001;53:245-282.
23. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, Brass LF. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997;272:4043-4049.
24. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002;122:1035-1047.
25. Tamura K, Wood JD. Effects of prolonged exposure to histamine on guinea pig intestinal neurons. Dig Dis Sci 1992;37:1084-1088.
26. Fu LW, Pan HL, Longhurst JC. Endogenous histamine stimulates ischemically sensitive abdominal visceral afferents through H1 receptors. Am J Physiol 1997;273:H2726-H2737.
27. Liu S, Hu HZ, Gao N, Gao C, Wang G, Wang X, Peck OC, Kim G, Gao X, Xia Y, Wood JD. Neuroimmune interactions in guinea pig stomach and small intestine. Am J Physiol Gastrointest Liver Physiol 2003;284:G154-G164.
28. Talley NJ, Phillips SF, Melton J III, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-674.
29. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol 2000;12:981-988.
30. Jensen MP, Turner LR, Turner JA, Romano JM. The use of multiple-item scales for pain intensity measurement in chronic pain patients. Pain 1996;67:35-40.
31. Lee E, Schiller LR, Fordtran JS. Quantification of colonic lamina propria cells by means of a morphometric point-counting method. Gastroenterology 1988;94:409-418.
32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
33. Raithel M, Schneider HT, Hahn EG. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand J Gastroenterol 1999;34:496-503.
34. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-1699.
35. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406.
36. Rao SS, Read NW, Davison PA, Bannister JJ, Holdsworth CD. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology 1987;93:1270-1275.
37. Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, Saba L, Naliboff B, Anton PA, Matin K. Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000;47:497-505.
38. Pockros PJ, Foroozan P. Golytely lavage versus a standard colonoscopy preparation. Effect on normal colonic mucosal histology. Gastroenterology 1985;88:545-548.
39. Wood JD. Neuropathophysiology of irritable bowel syndrome, J Clin Gastroenterol 2002;35(suppl 1):S11-S22.
40. Rao SS, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut 1988;29:342-345.
41. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990;35:157-172.
42. Bradesi S, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci 2001;68:1047-1056.
43. Wilhelm M, King B, Silverman AJ, Silver R. Gonadal steroids regulate the number and activational state of mast cells in the medial habenula. Endocrinology 2000;141:1178-1186.
44. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002;123:1686-1701.
45. Coelho AM, Fioramonti J, Bueno L. Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT Dig Dis Sci 1998;43:727-737.
46. Vergnolle N, Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 2000;14:257-266.
47. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum Al, Andrade-Gordon P Hollenberg MD, Wallace JL. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001;7:821-826.
48. Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 1982;128:2481-2486.
49. Kashiba H, Fukui H, Morikawa Y, Senba E. Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons. Brain Res Mol Brain Res 1999;66:24-34.
50. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-469.
51. Stefanini GF, Saggioro A, Alvisi V, Angelini G, Capurso L, di Lorenzo G, Dobrilla G, Dodero M, Galimberti M, Gasbarrini G. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995;30:535-541.
52. Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320-1326.
53. Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Muller-Lissner S, Pace F, Stockbrugger R, Vatn M, Whorwell P. Potential pitfalls in the differential diagnosis of irritable bowel syndrome. Digestion 2000;61:247-256.
54. Yu LC, Perdue MH. Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001;179:61-73.